Ríos Quiroz Anacelia, Finkler Christof, Huwyler Joerg, Mahler Hanns-Christian, Schmidt Roland, Koulov Atanas V
Late-Stage Pharmaceutical & Processing Development, Pharmaceutical Development & Supplies, Pharma Technical Development, Biologics Europe, F. Hoffman-La Roche Ltd., Basel 4070, Switzerland; Analytical Development & Quality Control, Pharma Technical Development, Biologics Europe, F. Hoffman-La Roche Ltd., Basel 4070, Switzerland; Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel 4056, Switzerland.
Analytical Development & Quality Control, Pharma Technical Development, Biologics Europe, F. Hoffman-La Roche Ltd., Basel 4070, Switzerland.
J Pharm Sci. 2016 Jul;105(7):2042-52. doi: 10.1016/j.xphs.2016.03.044. Epub 2016 Jun 8.
A number of new techniques for subvisible particle characterization in biotechnological products have emerged in the last decade. Although the pharmaceutical community is actively using them, the current knowledge about the analytical performance of some of these tools is still inadequate to support their routine use in the development of biopharmaceuticals (especially in the case of submicron methods). With the aim of increasing this knowledge and our understanding of the most prominent techniques for subvisible particle characterization, this study reports the results of a systematic evaluation of their accuracy. Our results showed a marked overcounting effect especially for low concentrated samples and particles fragile in nature. Furthermore, we established the relative sample size distribution as the most important contributor to an instrument's performance in accuracy counting. The smaller the representation of a particle size within a solution, the more difficulty the instruments had in providing an accurate count. These findings correlate with a recent study examining the principal factors influencing the precision of the subvisible particle measurements. A more thorough understanding of the capabilities of the different particle characterization methods provided here will help guide the application of these methods and the interpretation of results in subvisible particle characterization studies.
在过去十年中,出现了许多用于生物技术产品中亚可见颗粒表征的新技术。尽管制药界正在积极使用这些技术,但目前对于其中一些工具的分析性能的了解仍不足以支持它们在生物制药开发中的常规使用(特别是在亚微米方法的情况下)。为了增加这方面的知识以及我们对亚可见颗粒表征最突出技术的理解,本研究报告了对其准确性进行系统评估的结果。我们的结果显示出明显的计数过多效应,尤其是对于低浓度样品和性质脆弱的颗粒。此外,我们确定相对样品尺寸分布是仪器在准确计数性能方面最重要的因素。溶液中某一粒径的占比越小,仪器在提供准确计数方面就越困难。这些发现与最近一项研究亚可见颗粒测量精度影响主要因素的研究相关。此处对不同颗粒表征方法能力的更深入理解将有助于指导这些方法在亚可见颗粒表征研究中的应用以及结果的解释。